Yazan Migdady

419 total citations
19 papers, 239 citations indexed

About

Yazan Migdady is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Yazan Migdady has authored 19 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Hematology and 5 papers in Immunology. Recurrent topics in Yazan Migdady's work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Yazan Migdady is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Yazan Migdady collaborates with scholars based in United States, Netherlands and United Kingdom. Yazan Migdady's co-authors include Adam J. Olszewski, Michael Murphy, Joachim J. Bosboom, Denise P. Veelo, Bart F. Geerts, Alexander P. J. Vlaar, Takae Brewer, Kim R. Kampen, Christopher R. Cogle and Najmaldin Saki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yazan Migdady

17 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yazan Migdady United States 10 84 79 51 45 40 19 239
Anne‐Claire Gac France 12 70 0.8× 100 1.3× 15 0.3× 62 1.4× 41 1.0× 30 342
A Miliani Italy 6 195 2.3× 140 1.8× 10 0.2× 26 0.6× 55 1.4× 24 320
JC Meijers Netherlands 7 430 5.1× 16 0.2× 11 0.2× 318 7.1× 61 1.5× 9 538
Taisuke Ishii Japan 9 43 0.5× 22 0.3× 7 0.1× 31 0.7× 37 0.9× 25 211
Shane G. Supple Australia 5 66 0.8× 45 0.6× 10 0.2× 14 0.3× 27 0.7× 6 224
Giuseppe Pellegris Italy 11 169 2.0× 175 2.2× 12 0.2× 30 0.7× 109 2.7× 20 365
Yusuke Shiozawa Japan 9 82 1.0× 45 0.6× 4 0.1× 48 1.1× 66 1.6× 19 258
Matthew Lumley United Kingdom 7 144 1.7× 94 1.2× 4 0.1× 61 1.4× 60 1.5× 9 304
Akinobu Funatsu Japan 11 263 3.1× 18 0.2× 3 0.1× 63 1.4× 28 0.7× 22 354
Isabelle Luquet France 13 499 5.9× 88 1.1× 14 0.3× 159 3.5× 41 1.0× 45 636

Countries citing papers authored by Yazan Migdady

Since Specialization
Citations

This map shows the geographic impact of Yazan Migdady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazan Migdady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazan Migdady more than expected).

Fields of papers citing papers by Yazan Migdady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yazan Migdady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazan Migdady. The network helps show where Yazan Migdady may publish in the future.

Co-authorship network of co-authors of Yazan Migdady

This figure shows the co-authorship network connecting the top 25 collaborators of Yazan Migdady. A scholar is included among the top collaborators of Yazan Migdady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yazan Migdady. Yazan Migdady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Maiti, Abhishek, Jeremy Ramdial, Brandon Cieniewicz, et al.. (2025). First-in-human study of autologous chimeric engulfment receptor T-cell CER-1236 targeting TIM-4-l in acute myeloid leukemia (CertainT-1).. Journal of Clinical Oncology. 43(16_suppl).
2.
3.
Kaempf, Andy, et al.. (2023). A retrospective validation of the IPSS-M molecular score in primary and therapy-related myelodysplastic syndromes (MDS). Leukemia & lymphoma. 64(10). 1689–1694. 2 indexed citations
4.
Pavletic, Steven Z., et al.. (2023). Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes. The Cancer Journal. 29(3). 179–187.
5.
6.
Migdady, Yazan, Asiri Ediriwickrema, Ryan P. Jackson, et al.. (2020). Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review. Blood Advances. 4(5). 815–818. 28 indexed citations
7.
Bosboom, Joachim J., Yazan Migdady, Denise P. Veelo, et al.. (2019). Transfusion-Associated Circulatory Overload: A Clinical Perspective. Transfusion Medicine Reviews. 33(2). 69–77. 44 indexed citations
8.
Migdady, Yazan, Yiqin Xiong, Karen Dresser, et al.. (2018). Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. Journal for ImmunoTherapy of Cancer. 6(1). 42–42. 16 indexed citations
9.
Migdady, Yazan, John Barnard, Najla Al Ali, et al.. (2018). Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis. Clinical Lymphoma Myeloma & Leukemia. 18(8). 528–532. 15 indexed citations
10.
11.
Bosboom, Joachim J., Yazan Migdady, Denise P. Veelo, et al.. (2018). Transfusion‐associated circulatory overload—a systematic review of diagnostic biomarkers. Transfusion. 59(2). 795–805. 21 indexed citations
12.
13.
Cogle, Christopher R., et al.. (2015). Acute myeloid leukemia in the vascular niche. Cancer Letters. 380(2). 552–560. 47 indexed citations
14.
Migdady, Yazan, et al.. (2015). Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis. Leukemia & lymphoma. 57(3). 676–684. 11 indexed citations
15.
Chahin, Abdullah, Steven M. Opal, Jorge Zorzópulos, et al.. (2014). The Novel Immunotherapeutic Oligodeoxynucleotide IMT504 Protects Neutropenic Animals from Fatal Pseudomonas aeruginosa Bacteremia and Sepsis. Antimicrobial Agents and Chemotherapy. 59(2). 1225–1229. 11 indexed citations
16.
Olszewski, Adam J., Yazan Migdady, Susan K. Boolbol, et al.. (2013). Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study. Breast Cancer Research and Treatment. 138(1). 215–223. 21 indexed citations
17.
Migdady, Yazan, et al.. (2013). Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: Application and outcomes. The Breast. 22(5). 793–798. 14 indexed citations
18.
Migdady, Yazan, et al.. (2012). Impact of adjuvant chemotherapy on recurrence-free survival in patients with pT1a/b hormone-negative and HER2-positive breast cancer.. Journal of Clinical Oncology. 30(15_suppl). 1034–1034. 1 indexed citations
19.
Migdady, Yazan & Adam J. Olszewski. (2011). Paroxysmal Nocturnal Hemoglobinuria Presenting with a Left Intraventricular Thrombus in a Patient with Prior Thymoma and Aplastic Anemia. Clinical Medicine Insights Oncology. 5. 343–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Claire Gac Breakdown of academic impact, for papers by A Miliani Breakdown of academic impact, for papers by JC Meijers Breakdown of academic impact, for papers by Taisuke Ishii Breakdown of academic impact, for papers by Shane G. Supple Breakdown of academic impact, for papers by Giuseppe Pellegris Breakdown of academic impact, for papers by Yusuke Shiozawa Breakdown of academic impact, for papers by Matthew Lumley Breakdown of academic impact, for papers by Akinobu Funatsu Breakdown of academic impact, for papers by Isabelle Luquet
Rankless by CCL
2026